Emily Rosenich

6PUBLICATIONS
14CO-AUTHORS
Medical devicesEpidemiology not elsewhere classifiedEpidemiological methodsMajor global burdens of diseaseComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 19, 2026
Pilot feasibility, acceptability, and tolerability of researcher-delivered apolipoprotein E (APOE) disclosure via videoconferencing in Australian adults at-risk of dementia.

|Nov 18, 2025
Interest in apolipoprotein E (APOE) disclosure among at-risk, cognitively unimpaired, community-dwelling Australian adults.

Emily Rosenich, Hannah Olver, Hannah Cummins

|Mar 17, 2023
Multidomain modifiable dementia risk factors are associated with poorer cognition in midlife.

Lisa Bransby, Emily Rosenich, Rachel F Buckley

|Feb 16, 2022
Differential Effects of APOE and Modifiable Risk Factors on Hippocampal Volume Loss and Memory Decline in Aβ- and Aβ+ Older Adults.

Emily Rosenich, Lisa Bransby, Nawaf Yassi

|Feb 25, 2020
Cognitive Reserve as an Emerging Concept in Stroke Recovery.

Emily Rosenich, Brenton Hordacre, Catherine Paquet

|Oct 11, 2018
Does rTMS reduce depressive symptoms in young people who have not responded to antidepressants?

Emily Rosenich, Shane Gill, Patrick Clarke

Pageof 1

Frequent Collaborators

4 joint publications

Yen Ying Lim

3 joint publications

Lisa Bransby

3 joint publications

Paul Maruff

2 joint publications

Nawaf Yassi